Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
After food intake, the active form of GLP-1 is released into the circulation and activates specific G-protein coupled receptors
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
Instead of snacking and mindlessly eating when I wasn't hungry, food became fuel
Aiming for about 8 cups (64 ounces) of water each day is a good goal for most people
Maintenance Once stores are replete, maintenance is 1mg every two to three months for deficiency of dietary origin, or every two months where there has been neurological involvement
Insulin doses typically require reduction of 20 to 50 percent when starting tirzepatide to prevent hypoglycemia
US$ 20.65
US$ 23.37
US$ 29.08
US$ 24.80
